Kato H, Takeuchi M, Horita N, Ishido T, Mizuki R, Kawagoe T, Shibuya E, Yuda K, Ishido M, Mizuki Y, Hayashi T, Meguro A, Kirino Y, Minegishi K, Nakano H, Yoshimi R, Kurosawa M, Fukumoto T, Takeno M, Hotta K, Kaneko T, Mizuki N. HLA-A26 is a Risk Factor for Behcet’s Disease Ocular Lesions. Mod Rheumatol, 18:1-16, 2019.
Komiya T, Takase-Minegishi K, Sakurai N, Nagai H, Hamada N, Soejima Y, Sugiyama Y, Tsuchida N, Kunishita Y, Kishimoto D, Kobayashi K, Kamiyama R, Yoshimi R, Kirino Y, Ohno S, Nakajima H: Dose down-titration of biological disease-modifying antirheumatic drugs in daily clinical practice: Shared decision-making and patient treatment preferences in Japanese patients with rheumatoid arthritis. Int J Rheum Dis, 22(11):2009-2016, 2019.
Sugiyama Y, Yoshimi R, Takeno M, Kunishita Y, Kishimoto D, Kamiyama R, Kirino Y, Ohno S, Nakajima H：miR-1 is a novel biomarker for polymyositis/dermatomyositis-associated interstitial lung disease. Mod Rheumatol, 18:1-6, 2019.
Suzuki T, Horita N, Takeuchi M, Ishido T, Mizuki Y, Mizuki R, Kawagoe T, Shibuya E, Yuta K, Yamane T, Hayashi T, Meguro A, Ishido M, Minegishi K, Yoshimi R, Kirino Y, Kato S, Arimoto J, Fukumoto T, Ishigatsubo Y, Kurosawa M, Takeno M, Kaneko T, Mizuki N: Clinical features of early-stage possible Behcet’s disease patients with a variant-type major organ involvement in Japan. Mod Rheumatol, 29(4): 640-646, 2019.
Suwa A, Horita N, Ishido T, Takeuchi M, Kawagoe T, Shibuya E, Yamane T, Hayashi T, Meguro A, Ishido M, Minegishi K, Yoshimi R, Kirino Y, Kato S, Arimoto J, Fukumoto T, Ishigatsubo Y, Kurosawa M, Kaneko T, Takeno M, Mizuki N: The ocular involvement did not accompany with the genital ulcer or the gastrointestinal symptoms at the early stage of Behcet’s disease. Mod Rheumatol, 29(2): 357-362, 2019.
Shoji K, Yanishi K, Yoshimi R, Hamada N, Kondo K, Fujimoto K, Nakajima H, Kuwahara K, Higashi Y, Fukumoto Y, Murohara T, Matoba S, TACT Follow up Study Investigators: Impact of therapeutic angiogenesis using autologous bone marrow-derived mononuclear cells implantation in critical limb ischemia with scleroderma – subanalysis of the long-term clinical outcomes survey. Circ J, 83(3): 662-671, 2019.
Tsuchida N, Kirino Y, Soejima Y, Onodera M, Arai K, Tamura E, Ishikawa T, Kawai T, Uchiyama T, Nomura S, Kobayashi D, Taguri M, Mitsuhashi S, Mizuguchi T, Takata A, Miyake N, Nakajima H, Miyatake S, Matsumoto N : Haploinsufficiency of A20 caused by a novel nonsense variant or entire deletion of TNFAIP3 is clinically distinct from Behçet’s disease. Arthritis research & therapy, 21(1):137, 2019.
Furukawa H, Oka S, Kawasaki A, Hidaka M, Shimada K, Kondo Y, Ihata A, Matsushita T, Matsumoto T, Hashimoto A, Matsumoto I, Komiya A, Kobayashi K, Osada A, Katayama M, Okamoto A, Setoguchi K, Kono H, Hamaguchi Y, Matsui T, Fukui N, Tamura H, Takehara K, Nagaoka S, SugiiS, Sumida T, Tsuchiya N, Tohma S: Human leukocyte antigen in Japanese patients with idiopathic inflammatory myopathy. Modern Rheumatology 2019, DOI:10.1080/14397595.2019.1637593.
Mizuki Y, Horita N, Horie Y, Takeuchi M, Ishido T, Mizuki R, Kawagoe T, Shibuya E, Yuda K, Ishido M, Minegishi K, Yoshimi R, Kirino Y, Kato S, Arimoto J, Fukumoto T, Kurosawa M, Kitaichi N, Takeno M, Kaneko T, Mizuki N. The influence of HLA-B51 on clinical manifestations among Japanese patients with Behcet’s disease: a nationwide survey. Mod Rheumatol, 6:1-7, 2019.
Mitsuhashi M, Yoshimi R, Kishimoto D, Hidekawa C, Iizuka Y, Sakurai N, Kamiyama R, Kirino Y, Kondo Y, Mizuki N, Nakajima H. Refractory Optic Perineuritis Related to Granulomatosis with Polyangiitis Treated with Intensive Immunosuppressive Therapy Combined with Plasma Exchange. Mod Rheumatol Case Rep, 4(1):84-89, 2020.
Minegishi S, Kato S, Takase-Minegishi K, Horita N, Azushima K, Wakui H, Ishigami T, Kosuge M, Kimura K, Tamura K: Native T1 time and extracellular volume fraction in differentiation of normal myocardium from non-ischemic dilated and hypertrophic cardiomyopathy myocardium: A systematic review and meta-analysis. Int J Cardiol Heart Vasc, 7: 25, 2019.
総説
Kirino Y, Nakajima H. Clinical and genetic aspects of Behcet’s disease in Japan. Intern Med. 58(9):1199-207, 2019.
Yoshimi R: The diagnosis and management of vasculo-Behcet’s disease. Intern Med. 58(1): 3-4, 2019.
Yoshimi R, Yumiko Sugiyama: Prognostic factors for PM/DM-ILD. A dilemma of treatment intensity? Atlas of Science. http://atlasofscience.org/prognostic-factors-for-pm-dm-ild-a-dilemma-of-treatment-intensity/, 2019.
